MX2024007517A - Formas solidas de compuestos de pirazolo[3,4-d]pirimidina. - Google Patents
Formas solidas de compuestos de pirazolo[3,4-d]pirimidina.Info
- Publication number
- MX2024007517A MX2024007517A MX2024007517A MX2024007517A MX2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrazolo
- solid forms
- pyrimidine compounds
- pyrimidin
- pyrrolidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290136P | 2021-12-16 | 2021-12-16 | |
| PCT/US2022/081795 WO2023114995A1 (en) | 2021-12-16 | 2022-12-16 | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024007517A true MX2024007517A (es) | 2024-08-19 |
Family
ID=85172741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024007517A MX2024007517A (es) | 2021-12-16 | 2022-12-16 | Formas solidas de compuestos de pirazolo[3,4-d]pirimidina. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12012412B2 (https=) |
| EP (1) | EP4448529A1 (https=) |
| JP (1) | JP2024546844A (https=) |
| KR (1) | KR20240119299A (https=) |
| CN (1) | CN118401525A (https=) |
| AU (2) | AU2022416644B2 (https=) |
| CA (1) | CA3242577A1 (https=) |
| IL (1) | IL313314A (https=) |
| MX (1) | MX2024007517A (https=) |
| TW (1) | TW202333676A (https=) |
| WO (1) | WO2023114995A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12012412B2 (en) * | 2021-12-16 | 2024-06-18 | Pfizer Inc. | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
| AU2024329573A1 (en) * | 2023-08-22 | 2026-04-02 | Cardurion Pharmaceuticals, Inc. | Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| RS52166B (sr) * | 2007-05-11 | 2012-08-31 | Pfizer Inc. | Amino-heterociklična jedinjenja |
| CN109893653A (zh) * | 2017-12-11 | 2019-06-18 | 王慧敏 | Pde9抑制剂的新用途 |
| US12012412B2 (en) | 2021-12-16 | 2024-06-18 | Pfizer Inc. | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
-
2022
- 2022-12-16 US US18/082,622 patent/US12012412B2/en active Active
- 2022-12-16 CN CN202280083751.7A patent/CN118401525A/zh active Pending
- 2022-12-16 AU AU2022416644A patent/AU2022416644B2/en active Active
- 2022-12-16 IL IL313314A patent/IL313314A/en unknown
- 2022-12-16 EP EP22854339.3A patent/EP4448529A1/en active Pending
- 2022-12-16 JP JP2024535383A patent/JP2024546844A/ja active Pending
- 2022-12-16 WO PCT/US2022/081795 patent/WO2023114995A1/en not_active Ceased
- 2022-12-16 MX MX2024007517A patent/MX2024007517A/es unknown
- 2022-12-16 TW TW111148528A patent/TW202333676A/zh unknown
- 2022-12-16 CA CA3242577A patent/CA3242577A1/en active Pending
- 2022-12-16 KR KR1020247023041A patent/KR20240119299A/ko active Pending
-
2024
- 2024-05-06 US US18/655,795 patent/US20240300961A1/en active Pending
-
2025
- 2025-12-03 AU AU2025275149A patent/AU2025275149A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022416644A1 (en) | 2024-07-04 |
| NZ812114A (en) | 2025-08-29 |
| AU2025275149A1 (en) | 2026-01-08 |
| CA3242577A1 (en) | 2023-06-22 |
| KR20240119299A (ko) | 2024-08-06 |
| EP4448529A1 (en) | 2024-10-23 |
| TW202333676A (zh) | 2023-09-01 |
| CN118401525A (zh) | 2024-07-26 |
| IL313314A (en) | 2024-08-01 |
| JP2024546844A (ja) | 2024-12-26 |
| US12012412B2 (en) | 2024-06-18 |
| US20230192707A1 (en) | 2023-06-22 |
| WO2023114995A1 (en) | 2023-06-22 |
| AU2022416644B2 (en) | 2025-09-11 |
| US20240300961A1 (en) | 2024-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024007517A (es) | Formas solidas de compuestos de pirazolo[3,4-d]pirimidina. | |
| MX2021003241A (es) | Sal de tosilato de pirrolo[2,3-d]pirimidina, forma cristalina de la misma y proceso de fabricacion e intermediario al mismo. | |
| BRPI0314001B8 (pt) | pirazolopirimidinas como inibidores de cinase dependente de ciclina e composição farmacêutica compreendendo as mesmas | |
| ATE362474T1 (de) | Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen | |
| ATE470668T1 (de) | Pyrazolopyrimidine als inhibitoren von cyclinabhängiger kinase zur behandlung von krebs | |
| BR9609011A (pt) | Composto | |
| RU2011116928A (ru) | Гетероциклические ингибиторы jак киназы | |
| MX2020009586A (es) | Compuestos de (2-azabiciclo[3.1.0]hexan-2-il)pirazolo[1,5-a]pirimi dina e imidazo[1,2-b]piridazina sustituidos como inhibidores de cinasas trk. | |
| TW200745128A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
| MY141978A (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| MX385576B (es) | Derivados de [1,2,4]triazol[1,5-a]pirimidina como inhibidores de pde2 | |
| CL2008001862A1 (es) | Forma cristalina i, iii e hidratada de 6-{difluoro-[6-(1-metil-1h-pirazol-4-il)[1,2,4]triazolo[4,3-b]piridazin-3-il]metil}quinolina; composicion farmaceutica que las comprende; y su uso para prevenir o tratar un un trastorno proliferativo celular. | |
| TW200745127A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
| UY37559A (es) | Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton | |
| CY1110666T1 (el) | Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων | |
| MX2020012636A (es) | Formas de monohidrato y cristalinas de 6-[(3s,4s)-4-metil-1-(pirim idin-2- ilmetil)pirrolidin-3-il]-3-tetrahidropiran-4-il-7h-imidazo [1,5-a]pirazin-8- ona. | |
| MX2019005123A (es) | Compuestos de [1,2,4]triazolo[1,5-a]pirimidina como inhibidores de pde2. | |
| WO2004106340A3 (en) | 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF | |
| GB2552269A (en) | Substituted pyrrolo(2,3-D)pyrimidines for selectively targeting tumor cells with fr-alpha and fr-beta type receptors | |
| ATE309246T1 (de) | 1-(alkyl), 1-(heteroaryl)alkyl und 1-(aryl)alkyl)-7-(pyrimidin-4-yl)-imidazo(1,2-a pyrimidin-5(h)- one derivate | |
| DK0678092T3 (da) | 5-alkoxy [1,2,4]triazolo[1,5-c]pyrimidin-2(3H)-thion-forbindelser og anvendelse deraf til fremstilling af 2,2'-dithiobis(5- | |
| DE69930416D1 (de) | Cgmp pde5 inhibitoren zur inhalationsbehandlung von sexueller dysfunktion | |
| MX2022014940A (es) | Derivados de pirrolo[2,3-d]pirimidina. | |
| MX383514B (es) | Pirrolo[2,3-d]piridazin-4-onas sustituidas y pirazolo[3,4-d]piridazin-4-onas como inhibidores de la proteína quinasa. | |
| NZ812114B2 (en) | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |